On Oct. 7, 2020, in a continuing effort to provide the facts about ID NOW to support public…
On Oct. 6, 2020, Oragenics announced receipt of feedback to its Type B Pre-IND Meeting Request from the…
On Oct. 6, 2020, Hologic announced that its Aptimaﾮ SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA)…
On Oct. 5, 2020, the FDA awarded a research contract to the Stanford University School of Medicine to…
On Oct. 5, 2020, Corvus Pharmaceuticals announced that it has initiated a Phase 1 study to investigate a…
On Oct. 1, 2020, the FDA approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the first-line treatment…
On Oct. 2, 2020, LabCorp announced that it had received an Emergency Use Authorization (EUA) from the FDA…
On Sept. 29, 2020, Oxford Immunotec announced that it had received clearance from the FDA to amend the…
On Sept. 29, 2020, Windtree Therapeutics announced that FDA had accepted its Investigational New Drug application for a…
On Sept. 28, 2020, Hologic announced that its Panther Fusionﾮ SARS-CoV-2 assay had received Emergency Use Authorization (EUA)…
On Sept. 28, 2020, INOVIO announced the U.S. Food and Drug Administration (FDA) had notified the company that…
On Sept. 24, 2020, the U.S. Department of Health and Human Services and the U.S. Food and Drug…
On Sept. 23, 2020, the FDA issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care…
On Sept. 22, 2020, the FDA announced it had launched the Digital Health Center of Excellence within the…
On Sept. 18, 2020, Roche announced the launch of its Elecsysﾮ Anti-SARS-CoV-2 S antibody test for markets accepting…
On Sept. 16, 2020, AXIM Biotechnologies announced that it had filed an Emergency Use Authorization (EUA) application with…
On Sept. 15, 2020, the FDA awarded a $5.4 million research contract to the University of Liverpool and…
On Sept. 15, 2020, the FDA published comparative performance data for some authorized COVID-19 molecular diagnostic tests. The…
On Sept. 14, 2020, Vaxart announced that the FDA had completed its review of the Companyﾒs Investigational New…
On Sept. 12, 2020, Pfizer and BioNTech announced that they had submitted an amended protocol to the FDA…
On Sept. 11, 2020, Todos Medical announced that the FDA has added the TODOS 2019-nCoV RT-qPCR Detection Kit…
On Sept. 10, 2020, Accelerate Diagnostics and BioCheck announced that the FDA had issued an Emergency Use Authorization…
On Sept. 9, 2020, Pfizer and BioNTech announced that they had submitted an amended protocol to the FDA…
On Sept. 10, 2020, GlaxoSmithKline and Innoviva announced the U.S. Food and Drug Administration (FDA) had approved a…
On Sept. 8, 2020, INOVIO announced that Thermo Fisher Scientific, the world leader in serving science, had signed…
On Sept. 3, 2020, OraSure Technologies announced that its ORAcollect-ﾷRNA (OR-100) collection device was included along with other…
On Sept. 3, 2020, Roche announced that the cobas SARS-CoV-2 & Influenza A/B Test for use on the…
On Sept. 1, 2020, Roche announced FDA approval for the cobasﾮ HIV-1/HIV-2 Qualitative Test for use on the…
On Sept. 1, 2020, City of Hope announced that it was investigating an innovative treatment for cancer patients…
On Aug. 31, 2020, T2 Biosystems announced that the FDA had issued an Emergency Use Authorization (EUA) for…